Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Biotechnology company Abivax has announced its inclusion in the Nasdaq Biotechnology Index, effective as of market opening on December 22, 2025.
Biotechnology company Abivax has announced the acceptance of 22 scientific abstracts concerning its drug candidate obefazimod for chronic inflammatory…
The French biotechnology company's stock is up 2.65% this Thursday, December 18, at midday, amidst a series of target upgrades by international analys…
Biotechnology company Abivax has released its financial results for the third quarter of 2025, reporting cash and cash equivalents of 589.7 million eu…
Abivax shares experienced a decline at the opening on Tuesday, December 16, 2025, despite a strong annual performance and a promising therapeutic outl…
Abivax shares fell by 9.12% on Tuesday, December 16, 2025, closing at 94.70 euros, down from 104.20 euros the previous day. This downturn follows the …
Abivax stock has climbed 15.05% this Wednesday, December 10, reaching €120.80 by midday, up from a close of €105 the previous day. This latest increas…
Abivax stock closed on Wednesday, December 10, at 115 euros on Euronext Paris, marking a 9.52% increase from the previous day, amid rumors of potentia…
Abivax shares closed on Tuesday, December 9th at 105 euros on Euronext Paris, marking a 5.11% increase from the previous day. This rise goes against t…
